Citigroup
STJ

Citigroup’s St Jude Medical STJ Stock Holding History

Citigroup’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-200,000
Closed -$16M – 7539
2016
Q4 		$16M Sell
200,000
-16,800
-8% -$1.33M 0.01% 890
2016
Q3 		$17.3M Buy
216,800
+176,400
+437% +$14.2M 0.02% 767
2016
Q2 		$3.15M Sell
40,400
-700
-2% -$49.9K ﹤0.01% 1977
2016
Q1 		$2.26M Buy
41,100
+25,700
+167% +$1.4M ﹤0.01% 2350
2015
Q4 		$952K Sell
15,400
-38,500
-71% -$2.43M ﹤0.01% 3194
2015
Q3 		$3.4M Sell
53,900
-12,700
-19% -$906K ﹤0.01% 2003
2015
Q2 		$4.87M Sell
66,600
-115,200
-63% -$8.32M ﹤0.01% 1753
2015
Q1 		$11.9M Buy
181,800
+46,800
+35% +$3.11M 0.01% 1061
2014
Q4 		$8.78M Buy
135,000
+45,000
+50% +$2.9M 0.01% 1371
2014
Q3 		$5.41M Sell
90,000
-65,100
-42% -$4.25M ﹤0.01% 1767
2014
Q2 		$10.7M Buy
155,100
+104,800
+208% +$6.79M 0.01% 1213
2014
Q1 		$3.29M Sell
50,300
-54,900
-52% -$3.57M ﹤0.01% 2027
2013
Q4 		$6.52M Sell
105,200
-28,700
-21% -$1.66M 0.01% 1574
2013
Q3 		$7.18M Sell
133,900
-20,700
-13% -$1.07M 0.01% 1449
2013
Q2 		$7.05M Buy
+154,600
New +$6.7M 0.01% 1355

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Citigroup's STJ Position: Q1 2017 in Review

Citigroup sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 4,594,746 shares — an estimated $368M sold.

Citigroup first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $368M in Q4 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Citigroup reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Citigroup sold 4,594,746 St Jude Medical shares in Q1 2017, an estimated $368M.
  • Citigroup first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Citigroup's St Jude Medical position peaked at $368M in Q4 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.